Literature DB >> 15737977

Global trends in breast cancer incidence and mortality 1973-1997.

Michelle D Althuis1, Jaclyn M Dozier, William F Anderson, Susan S Devesa, Louise A Brinton.   

Abstract

BACKGROUND: Worldwide, breast cancer is the most common cancer and is the leading cause of cancer death among women.
METHODS: To describe global trends, we compared age-adjusted incidence and mortality rates over three decades (from 1973-77 to 1993-97) and across several continents.
RESULTS: Both breast cancer incidence and mortality rates varied 4-fold by geographic location between countries with the highest and lowest rates. Recent (1993-1997) incidence rates ranged from 27/100,000 in Asian countries to 97/100,000 among US white women. Overall, North American and northern European countries had the highest incidence rates of breast cancer; intermediate levels were reported in Western Europe, Oceania, Scandinavia, and Israel; and Eastern Europe, South and Latin America, and Asia had the lowest levels. Breast cancer incidence rose 30-40% from the 1970s to the 1990s in most countries, with the most marked increases among women aged > or =50 years. Mortality from breast cancer paralleled incidence: it was highest in the countries with the highest incidence rates (between 17/100,000 and 27/100,000), lowest in Latin America and Asia (7-14/100,000), and rose most rapidly in countries with the lowest rates.
CONCLUSIONS: Breast cancer incidence and mortality rates remain highest in developed countries compared with developing countries, as a result of differential use of screening mammograms and disparities in lifestyle and hereditary factors. Future studies assessing the combined contributions of both environmental and hereditary factors may provide explanations for worldwide differences in incidence and mortality rates.

Entities:  

Mesh:

Year:  2005        PMID: 15737977     DOI: 10.1093/ije/dyh414

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  151 in total

1.  Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.

Authors:  Adel Denewer; Osama Hussein; Omar Farouk; Waleed Elnahas; Ashraf Khater; Aiman El-Saed
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

Authors:  Garnet L Anderson; Rowan T Chlebowski; Aaron K Aragaki; Lewis H Kuller; JoAnn E Manson; Margery Gass; Elizabeth Bluhm; Stephanie Connelly; F Allan Hubbell; Dorothy Lane; Lisa Martin; Judith Ockene; Thomas Rohan; Robert Schenken; Jean Wactawski-Wende
Journal:  Lancet Oncol       Date:  2012-03-07       Impact factor: 41.316

3.  Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998.

Authors:  J C Kaiser; P Jacob; R Meckbach; H M Cullings
Journal:  Radiat Environ Biophys       Date:  2011-09-23       Impact factor: 1.925

4.  Occupation and breast cancer risk among Shanghai women in a population-based cohort study.

Authors:  Bu-Tian Ji; Aaron Blair; Xiao-Ou Shu; Wong-Ho Chow; Michael Hauptmann; Mustafa Dosemeci; Gong Yang; Jay Lubin; Yu-Tang Gao; Nathaniel Rothman; Wei Zheng
Journal:  Am J Ind Med       Date:  2008-02       Impact factor: 2.214

5.  Role of scintimammography in the diagnosis of breast cancer.

Authors:  Birendra Kishore Das; Biswa Mohan Biswal; Murali Bhavaraju
Journal:  Malays J Med Sci       Date:  2006-01

6.  iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?

Authors:  Christina Bluemel; Andreas Cramer; Christoph Grossmann; Georg W Kajdi; Uwe Malzahn; Nora Lamp; Heinz-Jakob Langen; Jan Schmid; Andreas K Buck; Hanns-Jörg Grimminger; Ken Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-09       Impact factor: 9.236

7.  Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients.

Authors:  Nasir Ali Afsar; Mike Ufer; Sierk Haenisch; Cornelia Remmler; Ahmed Mateen; Ahmed Usman; Khwaja Zafar Ahmed; Hakimuddin Razi Ahmad; Ingolf Cascorbi
Journal:  Eur J Clin Pharmacol       Date:  2011-10-20       Impact factor: 2.953

8.  Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China.

Authors:  Wenjin Li; Roberta M Ray; David B Thomas; Michael Yost; Scott Davis; Norman Breslow; Dao Li Gao; E Dawn Fitzgibbons; Janice E Camp; Eva Wong; Karen J Wernli; Harvey Checkoway
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

9.  Mouse mammary tumor virus-like virus infection and the risk of human breast cancer: a meta-analysis.

Authors:  Faliang Wang; Jinchao Hou; Qi Shen; Yongfang Yue; Fajun Xie; Xian Wang; Hongchuan Jin
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

10.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.